We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Biomarker-based staging of Alzheimer disease: rationale and clinical applications

    Disease staging, whereby the spatial extent and load of brain pathology are used to estimate the severity of Alzheimer disease (AD), is pivotal to...

    Joseph Therriault, Suzanne E. Schindler, ... Pedro Rosa-Neto in Nature Reviews Neurology
    Article 01 March 2024
  2. Thyroid transcription factor‐1 expression in lung neuroendocrine tumours: a gender-related biomarker?

    Purpose

    Thyroid transcription factor‐1 (TTF‐1) assessed by immunohistochemistry (IHC) is a specific biomarker for lung adenocarcinoma, and is commonly...

    Anna La Salvia, Alessandra Siciliani, ... Antongiulio Faggiano in Endocrine
    Article Open access 30 September 2023
  3. Decoding the glycoproteome: a new frontier for biomarker discovery in cancer

    Cancer early detection and treatment response prediction continue to pose significant challenges. Cancer liquid biopsies focusing on detecting...

    Kai He, Maryam Baniasad, ... Carolyn Bertozzi in Journal of Hematology & Oncology
    Article Open access 22 March 2024
  4. Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients

    Background

    Accurately predicting the response to neoadjuvant chemotherapy (NAC) in breast cancer patients is crucial for guiding treatment strategies...

    Mijia Wang, Zhendong Wei, ... Haidong Zhao in Diagnostic Pathology
    Article Open access 20 March 2024
  5. Exosomal microRNAs in Parkinson’s disease: insights into biomarker potential and disease pathology

    Parkinson’s disease (PD) is a prevalent neurodegenerative condition primarily affecting the elderly population. Despite its high incidence in aged...

    Deepthy Chandran, Syam Krishnan, ... Srinivas Gopala in Neurological Sciences
    Article 27 March 2024
  6. Changes in glutamic oxaloacetic transaminase 2 during rat physiological and pathological cardiomyocyte hypertrophy

    Background

    Physiological and pathological cardiomyocyte hypertrophy are important pathophysiological processes of adult congenital heart...

    **n Liu, **aolu Li, Haotan Zhou in BMC Cardiovascular Disorders
    Article Open access 05 December 2023
  7. Vasohibin-1 Expression Can Predict Pathological Complete Remission of Advanced Bladder Cancer with Neoadjuvant Chemotherapy

    Background and purpose

    Neoadjuvant chemotherapy (NAC) is a well-established standard practice in invasive bladder cancer (BCa), however patient...

    Minami Omura, Takeo Kosaka, ... Mototsugu Oya in Annals of Surgical Oncology
    Article Open access 20 February 2024
  8. Functional connectivity changes in neurodegenerative biomarker-positive athletes with repeated concussions

    Multimodal biomarkers may identify former contact sports athletes with repeated concussions and at risk for dementia. Our study aims to investigate...

    Indira Garcia-Cordero, Anna Vasilevskaya, ... Maria C. Tartaglia in Journal of Neurology
    Article 08 April 2024
  9. Proline-Rich Protein 11 Overexpression in Invasive Breast Carcinoma: A Potential Diagnosis Biomarker

    Purpose

    This study aims to investigated the expression of proline-rich protein 11 (PRR11) as a diagnostic biomarker of invasive breast cancer and to...

    Kaoutar Anouar Tadlaoui, Soukayna Alaoui Sosse, ... Moulay Mustapha Ennaji in Indian Journal of Gynecologic Oncology
    Article 22 April 2023
  10. ADAMTS4 is involved in the production of the Alzheimer disease amyloid biomarker APP669-711

    Amyloid-β (Aβ) deposition in the brain parenchyma is one of the pathological hallmarks of Alzheimer disease (AD). We have previously identified...

    Masaya Matsuzaki, Miyabishara Yokoyama, ... Taisuke Tomita in Molecular Psychiatry
    Article Open access 01 February 2023
  11. Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

    Anti-amyloid treatments for early symptomatic Alzheimer disease have recently become clinically available in some countries, which has greatly...

    Suzanne E. Schindler, Douglas Galasko, ... Oskar Hansson in Nature Reviews Neurology
    Article 12 June 2024
  12. Molecular biomarker approaches to prevention of post-traumatic osteoarthritis

    Up to 50% of individuals develop post-traumatic osteoarthritis (PTOA) within 10 years following knee-joint injuries such as anterior cruciate...

    Virginia Byers Kraus, Ming-Feng Hsueh in Nature Reviews Rheumatology
    Article 11 April 2024
  13. The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer

    Background

    Pancreatic ductal adenocarcinoma (PDAC) is one of the main causes of cancer mortality in the world. A characteristic feature of this cancer...

    Raquel Bodoque-Villar, David Padilla-Valverde, ... Leticia Serrano-Oviedo in World Journal of Surgical Oncology
    Article Open access 12 September 2023
  14. Alzheimer’s Disease Biomarker Decision-Making among Patients with Mild Cognitive Impairment and Their Care Partners

    Background

    Alzheimer’s disease (AD) biomarker tests can be ordered as part of the diagnostic workup of patients with mild cognitive impairment (MCI)....

    Chelsea G. Cox, C. R. Salazar, ... J. D. Grill in The Journal of Prevention of Alzheimer's Disease
    Article 08 January 2024
  15. Systemic immune-inflammation index in dural arteriovenous fistula: a feasible biomarker reflecting its clinical characteristics

    Purpose

    The systemic immune-inflammation index (SII), a marker of systemic inflammation, can be calculated using peripheral blood tests. Although the...

    Kota Kurisu, Toshiya Osanai, ... Miki Fujimura in Acta Neurochirurgica
    Article 16 April 2024
  16. Identification of a potential bioinformatics-based biomarker in keloids and its correlation with immune infiltration

    Keloid formation is a pathological consequence resulting from cutaneous irritation and injury, primarily attributed to excessive collagen matrix...

    Zihan Li, Chuwei Zhang, ... You Lang Zhou in European Journal of Medical Research
    Article Open access 02 November 2023
  17. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates

    Purpose

    BCL-2-associated athanogene 3 (BAG3) is an anti-apoptotic protein that plays an essential role in the onset and progression of multiple cancer...

    Binghao Gong, Yuan Huang, ... Cai Lv in European Journal of Medical Research
    Article Open access 01 February 2024
  18. Bioimpedance based biomarker for the detection of precancerous and cancerous lesions of the pancreas: feasibility animal study

    Background

    Pancreatic cancer (PC) remains a significant healthcare challenge due to its aggressive nature and poor prognosis. The current gold...

    Federica Dibennardo, Onur Fidaner, ... Martina Guidetti in Translational Medicine Communications
    Article Open access 03 May 2024
  19. Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization

    Abstract

    Conventional transarterial chemoembolization (cTACE) utilizing ethiodized oil as a chemotherapy carrier has become a standard treatment for...

    Mishal Mendiratta-Lala, Anum Aslam, ... Nicholas Fidelman in European Radiology
    Article Open access 06 November 2023
  20. Measuring cfDNA integrity as a biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients: a pilot study

    Purpose

    Circulating cell-free DNA (cfDNA) is a promising biomarker for predicting treatment response and disease outcomes in Breast Cancer (BC)...

    Camila Giro, Alayne M. T. D. Yamada, ... Auro del Giglio in Breast Cancer Research and Treatment
    Article 14 May 2024
Did you find what you were looking for? Share feedback.